Clinical Trial Update: Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the clinical efficacy of Synatura® in patients with chronic bronchitis-type COPD has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Synatura®

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Bronchitis, COPD | Phase 4 | Status: COMPLETED